5.32 - ASH Update #1 - Talquetamab NEJM
Dec 11, 2022•18 min
Episode description
Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast